Guardant Health Files 2024 10-K
Ticker: GH · Form: 10-K · Filed: 2025-02-20T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
Guardant Health dropped its 2024 10-K. Full financials for FY24, FY23, FY22 out.
AI Summary
Guardant Health, Inc. filed its 2024 10-K on February 20, 2025, reporting on its fiscal year ending December 31, 2024. The filing details the company's financial performance and business operations. Key figures and operational details for the fiscal years 2024, 2023, and 2022 are presented, including balance sheet information as of December 31st for those years.
Why It Matters
This filing provides investors and the public with a comprehensive overview of Guardant Health's financial health and strategic positioning for the fiscal year 2024, crucial for understanding its market performance and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard annual report and does not inherently indicate new risks beyond those typically associated with a publicly traded company in the healthcare sector.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Fiscal Year (Comparative reporting period)
- 2022 — Fiscal Year (Comparative reporting period)
Key Players & Entities
- Guardant Health, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-20 (date) — Filing date
- AmirAli Talasaz (person) — Co-Chief Executive Officer and Director
FAQ
What is the primary business of Guardant Health, Inc.?
Guardant Health, Inc. operates in the Medical Laboratories sector, as indicated by its SIC code 8071.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on February 20, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Who is listed as a key executive officer?
AmirAli Talasaz is listed as Co-Chief Executive Officer and Director.
What are the key dates for financial reporting in this filing?
The filing provides data for the fiscal years ending December 31, 2024, December 31, 2023, and December 31, 2022, as well as balance sheet information for December 31, 2021.
From the Filing
0001576280-25-000044.txt : 20250220 0001576280-25-000044.hdr.sgml : 20250220 20250220171757 ACCESSION NUMBER: 0001576280-25-000044 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 111 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250220 DATE AS OF CHANGE: 20250220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 25647294 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 10-K 1 gh-20241231.htm 10-K gh-20241231 false 2024 FY 0001576280 http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent 0.0071523 4 0.0160716 AmirAli Talasaz 364 Co-Chief Executive Officer and Director iso4217:USD xbrli:shares iso4217:USD xbrli:shares gh:segment gh:investment xbrli:pure gh:seat utr:D gh:trading_day gh:patent gh:tranche gh:grantee 0001576280 2024-01-01 2024-12-31 0001576280 2024-06-30 0001576280 2025-02-14 0001576280 2023-01-01 2023-12-31 0001576280 2024-12-31 0001576280 2023-12-31 0001576280 2022-01-01 2022-12-31 0001576280 us-gaap:CommonStockMember 2021-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001576280 us-gaap:RetainedEarningsMember 2021-12-31 0001576280 2021-12-31 0001576280 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001576280 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001576280 us-gaap:CommonStockMember 2022-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001576280 us-gaap:RetainedEarningsMember 2022-12-31 0001576280 2022-12-31 0001576280 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001576280 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001576280 us-gaap:CommonStockMember 2023-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001576280 us-gaap:RetainedEarningsMember 2023-12-31 0001576280 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001576280 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001576280 us-gaap:CommonStockMember 2024-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001576280 us-gaap:RetainedEarningsMember 2024-12-31 0001576280 gh:TwinStrandBiosciencesAndUniversityOfWashingtonVsGuardantHealthIncMember 2024-12-31 0001576280 2022-09-01 2022-09-30 0001576280 2023-06-01 2023-06-30 0001576280 gh:CustomerAMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-01-01 2024-12-31 0001576280 gh:CustomerAMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2023-01-01 2023-12-31 0001576280 gh:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-12-31 0001576280 gh:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-12-31 0001576280 gh:CustomerBMember us-gaap:CustomerConcentrationR